Early antibiotic treatment failure

Area of Science:

• Infectious Diseases
• Clinical Pharmacology
• Healthcare Management

Background:

• Treatment failure in infections lacks a standardized definition, hindering consistent assessment.
• Current definitions primarily rely on clinical signs, with limited integration of microbiological or biological markers.
• High reported treatment failure rates, up to 64%, indicate a significant clinical challenge.

Purpose of the Study:

• To review the definition, risk factors, and clinical relevance of treatment failure in infections.
• To highlight the need for consensus on validated variables and definitions for treatment failure.
• To explore strategies for stratifying patients and managing high-risk individuals.

Main Methods:

• Literature review and synthesis of existing data on treatment failure definitions and risk factors.
• Analysis of clinical relevance, including impact on hospital stay, mortality, and costs.
• Discussion of proposed future initiatives for consensus building and risk stratification.

Main Results:

• Major risk factors for treatment failure include inadequate antimicrobial spectrum and insufficient infection source control.
• Treatment failure is associated with significantly increased length of hospital stay, higher mortality, and greater healthcare costs.
• Specific patient subpopulations may experience unique risk factors influencing treatment outcomes.

Conclusions:

• Establishing consensus on validated definitions and variables for treatment failure is crucial.
• Investigating modifiable risk factors can lead to a treatment failure score for patient stratification.
• For high-risk patients, initial broad-spectrum antibiotics and adjusted dosing regimens are recommended.